The effect of endostatin and gemcitabine combined with HIFU on the animal xenograft model of human pancreatic cancer

Biomedicine and Pharmacotherapy

Volumn 64, Issue 5, 2010, Pages 309-312

  Wang, Rong sheng ^a   Liu, Ling xiang ^a   Gu, Yan hong ^a   Lin, Qing feng ^a   Guo, Ren hua ^a   Shu, Yong qian ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Endostatin; Gemcitabine; High intensity focused ultrasound (HIFU); Pancreatic cancer

Indexed keywords

ANTINEOPLASTIC AGENT; ENDOSTATIN; GEMCITABINE; RECOMBINANT HUMAN ENDOSTATIN; SODIUM CHLORIDE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER COMBINATION CHEMOTHERAPY; CANCER SIZE; CONTROLLED STUDY; DRUG EFFECT; DRUG TARGETING; FEMALE; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; HUMAN CELL; MICROVASCULATURE; MONOTHERAPY; MOUSE; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TISSUE SECTION; TUMOR NECROSIS; TUMOR VASCULARIZATION; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; DRUG DELIVERY SYSTEMS; ENDOSTATINS; FEMALE; HUMANS; MICE; MICE, INBRED BALB C; MICROVESSELS; PANCREATIC NEOPLASMS; RANDOM ALLOCATION; ULTRASONIC THERAPY; VASCULAR ENDOTHELIAL GROWTH FACTOR A; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77953286679     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2009.09.011     Document Type: Article

References (9)

1. Giroux V, Malicet C, Barthet M, et al. p8 is a new target of gemcitabine in pancreatic cancer cells. Clin Cancer Res 2006;12:235-241.
2. Rocha Lima CMSP, Flores AM. Gemcitabine doublets in advanced pancreatic cancer: should we move on? J Clin Oncol 2006;24:327-9.
3. Chun H, Kai L, Xiyin W, et al. Advanced non-small cell lung cancer the level of circulating endothelial cells in the research. Chin J Cancer 2006;28:780-3.
4. Folkman J. Antiangiogenesis in cancer therapy-endostatin and its mechanisms of action. Exp Cell Res 2006;312:594-607.
5. Yu Y, Moulton KS, Khan MK, et al. E-selectin is required for the antiangiogenic activity of endostatin. Proc Natl Acad Sci U S A 2004;101:8005-10.
6. Nyberg P, Heikkila P, Sorsa T, et al. Endostatin inhibits human tongue carcinoma cell invasion and intravasation and blocks the activation of matrix metalloprotease-2, -9, and -13, J Biol Chem 2003;278:22404-11.
7. Abdollahi A, Hlatky L, Huber PE. Endostatin: The logic of antiangiogenic therapy, Drug Resist Updat 2005;8:59-74.
8. Jain RK. Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy. Science 2005;307:58-62.
9. Rong-Sheng W, Qin-Xia M, Yong-Qian S, et al. High intensity focused ultrasound hyperthermia combined chemotherapy in the treatment of advanced pancreatic cancer. J Nanjing Med Univ 2003;23:460-3.